Anne Le Hir, Guillaume A Durand, José Boucraut, Annabelle Garnier, Marie Mura, Sylvain Diamantis, Michel Carles, Claire Durand, Cyril Schweitzer, Claire Audouard, Véronique Decroix, Romain Boyez, Anne Van Dendriessche, Alexandre Leclancher, Elsa Kaphan, Luce Barbat du Closel, Renaud Verdon, Damien du Cheyron, Astrid Vabret, Delphine Vergnon, Gilda Grard, Rémi Charrel, Xavier de Lamballerie, Carole Eldin
BACKGROUND: Immunization against the Yellow fever virus (YFV) with the 17D live-attenuated vaccine is the most effective way to prevent the disease. However, unexpected severe adverse events can occur. They consist in a neurological disease (YEL-AND), a viscerotropic disease (YEL-AVD), or anaphylaxis. In this article, we describe the epidemiology, clinical and biological features of YEL-AND and YEL-AVD cases reported to the French National Reference Center for Arboviruses (NRCA) in the past 10 years...
December 20, 2023: Journal of Travel Medicine